DRG International, Inc. FDA Inspection Record
DRG International, Inc. is an FDA-registered facility (FEI 2245285) located in Springfield, NJ, US. RegDataLab tracks 4 FDA inspections at this facility.
What FDA found at this site
- Latest inspection
- Apr 15, 2019: Voluntary Action Indicated (VAI)
- Inspections on record
- 4 (4 VAI)
- Last OAI inspection
- None on record
- Warning letters
- None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
- Recalls as the recalling firm
- 7, latest Jul 2, 2026
Inspections and what FDA cited
| Date | Result | What FDA cited |
|---|---|---|
| Apr 15, 2019 | Voluntary Action Indicated (VAI) | Procedures not adequately established or maintained (21 CFR 820.40) Quality audits - Lack of or inadequate procedures (21 CFR 820.22) Lack of or inadequate procedures (21 CFR 820.100(a)) DMR - not or inadequately maintained (21 CFR 820.181) and 2 more |
| Nov 26, 2014 | Voluntary Action Indicated (VAI) | Acceptable supplier records, inadequate records (21 CFR 820.50(a)(3)) Nonconforming product, Lack of or inadequate procedures (21 CFR 820.90(a)) Documentation (21 CFR 820.100(b)) |
| Jul 11, 2012 | Voluntary Action Indicated (VAI) | Quality Audit/Reaudit - conducted (21 CFR 820.22) Purchasing controls, Lack of or inadequate procedures (21 CFR 820.50) |
| Dec 15, 2009 | Voluntary Action Indicated (VAI) | Investigation of device failures (21 CFR 820.198(c)) |
Recalls
| Date | Class | Recall | Product and reason |
|---|---|---|---|
| Jul 2, 2026 | Class II | Z-0082-2027 | Sperm Ab ELISA;
Model/Catalog Number: EIA-1826;
Product Description: Sperm Ab ELISA (96… Potential for false negative patient results. |
| Jun 4, 2025 | Class III | Z-2265-2025 | Brand Name: T4 Total ELISA
Product Name: T4 Total ELISA
Model/Catalog Number… An incoming complaint reported that the expiration date on the kit box label and Certificate of Analysis (CoA) exceeded the shelf life of… |
| Oct 7, 2024 | Class II | Z-0921-2025 | DRG:HYBRiD-XL Insulin. Model/Catalog Number: HYE-5361 The user of the assay may either face a failure message during re-calibration of the Hybrid.XL instrument using the re-calibration R1 and R2… |
| Sep 13, 2024 | Class III | Z-0258-2025 | 17-OH Progesterone ELISA 96 well kit- An enzyme immunoassay for the quantitative in vitro… The High and Low Control acceptance ranges in the Certificate of Analysis (CofA) did not match the acceptance range information on the High… |
| Jul 5, 2024 | Class III | Z-2622-2024 | Product Name: Salivary Testosterone ELISA
Model/Catalog Number: SLV-3013
Product… Invalid Controls. The Low Control is out of range; too high which causes invalid runs that would result in repeating the runs and delays… |
| Dec 21, 2021 | Class II | Z-0896-2022 | C-Peptide ELISA : IVD measurement of C-Peptide in serum, plasma (EDTA-, heparin- or… ODs of the standards too low(< 0.6 ODmax) may cause invalid runs, delayed patient results are possible |
| Oct 18, 2021 | Class II | Z-0310-2022 | Total Thyroxine (T4) ELISA; REF EIA-1781 Firm has identified two lots of product that do not meet product shelf life, resulting in failed Controls. The clinical impact may be a… |
FDA record score
11 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.
8 records behind this number
| Record | Date | Points x age weight | Adds |
|---|---|---|---|
| Class II recall Z-0082-2027, this FEI as the recalling firm | Jul 2, 2026 | 4 x 1 | 4 |
| Class II recall Z-0921-2025, this FEI as the recalling firm | Oct 7, 2024 | 4 x 0.6 | 2.4 |
| Class II recall Z-0896-2022, this FEI as the recalling firm | Dec 21, 2021 | 4 x 0.6 | 2.4 |
| Inspection classified VAI | Apr 15, 2019 | 6 x 0.25 | 1.5 |
| Class II recall Z-0310-2022, this FEI as the recalling firm | Oct 18, 2021 | 4 x 0.25 | 1 |
| Inspection classified VAI | Nov 26, 2014 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Jul 11, 2012 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Dec 15, 2009 | 10 years or older, so it adds no points | 0 |
When each source was last refreshed
| Records | Last refreshed | Source as of | Status |
|---|---|---|---|
| Inspections | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Inspection citations | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions (warning letters, injunctions and other action types) | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
| Warning letter text | Nov 16, 2026 | Newest record Nov 10, 2026 | Current |
| Recalls (Enforcement Report) | Nov 16, 2026 | Newest record Nov 11, 2026 | Current |
| Form 483s and inspection documents | Nov 13, 2026 | Newest record Nov 12, 2026 | Current |
| Import refusals | Nov 15, 2026 | Newest record Nov 5, 2026 | Current |
Reviewing DRG International, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check DRG International, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Facility details
- Company
- DRG International, Inc.
- Location
- Springfield, NJ (US)
- Source
- device